Pricing Log in Create free account

Aquestive Therapeutics, Inc. (AQST) vs Evotec AG (EVO)

Aquestive Therapeutics, Inc. and Evotec AG are both Drug Manufacturers Specialty & Generic companies. Evotec AG is the larger, with a market value of $630.4M against $460.0M — 1.4× the size. Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 12.5% against 2.15%. Evotec AG has the higher net margin (−26.2% vs −162.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Evotec AG leads on 9 and Aquestive Therapeutics, Inc. on 7.

Valuation

Metric AQST EVO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 9.36 0.72 2.08
P/B n/m 0.81 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 8.55 0.74 2.87
Earnings yield (17.62%) (36.25%) (15.94%)
Free cash flow yield (8.90%) (32.04%) 0.00%

Profitability

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Gross margin 65.34% 11.42% 53.51%
Operating margin (114.12%) (21.35%) 0.00%
Net margin (162.33%) (26.20%) (2.45%)
Free cash flow margin (83.33%) 0.00% 0.00%
Return on equity 211.59% 0.00% (0.80%)
Return on assets (56.05%) 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 12.54% 2.15% 5.22%
EPS growth (last fiscal year) (52.94%) 44.89% 42.91%
Revenue growth, 5-year CAGR (0.58%) 9.28% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Debt to equity (0.72) 0.72 0.04
Current ratio 6.12 2.33 2.41
Net debt to EBITDA 1.57 (0.64) 1.01

Dividend

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Market cap 460.01m 630.44m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack